References
- Lamb LE, Sriskandan S, Tan LK. Bromine, bear-claw scratch fasciotomies, and the Eagle effect: management of group A streptococcal necrotising fasciitis and its association with trauma. Lancet Infect Dis. 2015;15:109–121.
- Monnickendam MA, McEvoy MB, Blake WA, et al. Necrotising fasciitis associated with invasive group A streptococcal infections in England and Wales. Adv Exp Med Biol. 1997;418:87–89.
- Olsen RJ, Musser JM. Molecular pathogenesis of necrotizing fasciitis. Annu Rev Pathol. 2010;5:1–31.
- Kaul R, McGeer A, Low DE, et al. Population-based surveillance for group A streptococcal necrotizing fasciitis: clinical features, prognostic indicators, and microbiologic analysis of seventy-seven cases. Ontario Group A Streptococcal Study. Am J Med. 1997;103:18–24.
- Nuwayhid ZB, Aronoff DM, Mulla ZD. Blunt trauma as a risk factor for group A streptococcal necrotizing fasciitis. Ann Epidemiol. 2007;17:878–881.
- Hamilton SM, Bayer CR, Stevens DL, et al. Muscle injury, vimentin expression, and nonsteroidal anti-inflammatory drugs predispose to cryptic group A streptococcal necrotizing infection. J Infect Dis. 2008;198:1692–1698.
- Seki M, Saito M, Iida K, et al. Onset of streptococcal toxic shock syndrome is accelerated by bruising in a mouse model. Microb Pathog. 2008;44:339–343.
- Walker MJ, Barnett TC, McArthur JD, et al. Disease manifestations and pathogenic mechanisms of Group A Streptococcus. Clin Microbiol Rev. 2014;27:264–301.
- Sumby P, Whitney AR, Graviss EA, et al. Genome-wide analysis of group A streptococci reveals a mutation that modulates global phenotype and disease specificity. PLoS Pathog. 2006;2:e5.
- Walker MJ, Hollands A, Sanderson-Smith ML, et al. DNase Sda1 provides selection pressure for a switch to invasive group A streptococcal infection. Nat Med. 2007;13:981–985.
- Iida K, Seki M, Saito M, et al. Capsule of Streptococcus pyogenes is essential for delayed death of mice in a model of streptococcal toxic shock syndrome. Microbiol Immunol. 2006;50:127–130.
- Turner CE, Dryden M, Holden MT, et al. Molecular analysis of an outbreak of lethal postpartum sepsis caused by. J Streptococcus pyogenes Clin Microbiol. 2013;51:2089–2095.
- Lynskey NN, Goulding D, Gierula M, et al. RocA truncation underpins hyper-encapsulation, carriage longevity and transmissibility of serotype M18 group A streptococci. PLoS Pathog. 2013;9:e1003842.
- Turner CE, Kurupati P, Jones MD, et al. Emerging role of the interleukin-8 cleaving enzyme SpyCEP in clinical Streptococcus pyogenes infection. J Infect Dis. 2009;200:555–563.
- Bankevich A, Nurk S, Antipov D, et al. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol. 2012;19:455–477.
- Carver TJ, Rutherford KM, Berriman M, et al. ACT: the Artemis Comparison Tool. Bioinformatics. 2005;21:3422–3423.
- Bonnarens F, Einhorn TA. Production of a standard closed fracture in laboratory animal bone. J Orthop Res. 1984;2:97–101.
- Macdonald W, Skirving AP, Scull ER. A device for producing experimental fractures. Acta Orthop Scand. 1988;59:542–544.
- Alam FM, Turner CE, Smith K, et al. Inactivation of the CovR/S virulence regulator impairs infection in an improved murine model of Streptococcus pyogenes naso-pharyngeal infection. PLoS One. 2013;8:e61655.
- Kurupati P, Turner CE, Tziona I, et al. Chemokine-cleaving Streptococcus pyogenes protease SpyCEP is necessary and sufficient for bacterial dissemination within soft tissues and the respiratory tract. Mol Microbiol. 2010;76:1387–1397.
- Shackelford C, Long G, Wolf J, et al. Qualitative and quantitative analysis of nonneoplastic lesions in toxicology studies. Toxicol Pathol. 2002;30:93–96.
- Lynskey NN, Banerji S, Johnson LA, et al. Rapid lymphatic dissemination of encapsulated group a streptococci via lymphatic vessel endothelial receptor-1 interaction. PLoS Pathog. 2015;11:e1005137.
- Chiang-Ni C, Zheng PX, Ho YR, et al. emm1/sequence type 28 strains of group A streptococci that express covR at early stationary phase are associated with increased growth and earlier SpeB secretion. J Clin Microbiol. 2009;47:3161–3169.
- Yoshida H, Ishigaki Y, Takizawa A, et al. Comparative genomics of the mucoid and nonmucoid strains of streptococcus pyogenes, isolated from the same patient with streptococcal meningitis. Genome Announc. 2015;3:e00221-15.
- Falaleeva M, Zurek OW, Watkins RL, et al. Transcription of the Streptococcus pyogenes hyaluronic acid capsule biosynthesis operon is regulated by previously unknown upstream elements. Infect Immun. 2014;82:5293–5307.
- Dobek GL, Fulkerson ND, Nicholas J, et al. Mouse model of muscle crush injury of the legs. Comp Med. 2013;63:227–232.
- Crisco JJ, Jokl P, Heinen GT, et al. A muscle contusion injury model. Biomechanics, physiology, and histology. Am J Sports Med. 1994;22:702–710.
- Probst C, Mirzayan MJ, Mommsen P, et al. Systemic inflammatory effects of traumatic brain injury, femur fracture, and shock: an experimental murine polytrauma model. Mediators Inflamm. 2012;2012:136020.
- Stevens DL. Streptococcal toxic shock syndrome associated with necrotizing fasciitis. Annu Rev Med. 2000;51:271–288.
- Bisno AL, Stevens DL. Streptococcal infections of skin and soft tissues. N Engl J Med. 1996;334:240–245.
- Zaleska M, Olszewski WL, Durlik M. The effectiveness of intermittent pneumatic compression in long-term therapy of lymphedema of lower limbs. Lymphat Res Biol. 2014;12:103–109.
- Engleberg NC, Heath A, Miller A, et al. Spontaneous mutations in the CsrRS two-component regulatory system of Streptococcus pyogenes result in enhanced virulence in a murine model of skin and soft tissue infection. J Infect Dis. 2001;183:1043–1054.
- Taylor J, Wojcik A. Upper limb compartment syndrome secondary to Streptococcus pyogenes (Group A streptococcus) infection. J Surg Case Rep. 2011;2011:3.
- Ashbaugh CD, Alberti S, Wessels MR. Molecular analysis of the capsule gene region of group A Streptococcus: the hasAB genes are sufficient for capsule expression. J Bacteriol. 1998;180:4955–4959.